https://clinicaltrials.gov/ct2/show/NCT02794285?type=Intr&cond=Lupus&phase=012345&lupd_s=02%2F01%2F2019&lupd_d=14
Condition : Active Systemic Lupus Erythematosus
Interventions : Biological: Anifrolumab; Drug: Placebo
Sponsors : AstraZeneca; PRA Health Sciences
Active, not recruiting
Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus
NCT02794285
Thu, 09 Jun 2016 12:00:00 EDT
